About Oriola
Oriola is a publicly listed company based in Espoo (Finland) founded in 1997. It operates as a pharmaceutical drugs and supplements are distributed by Oriola in Finland. The company has 816 employees. Oriola has completed 2 acquisitions, including ICT Health Support and Medinfo APS. Its website oriola.com draws about 10 thousand monthly visits. Oriola offers products and services including Pharmaceutical Distribution, Clinical Trial Services, and Dose Dispensing. Its focus areas include Pharmaceutical Distributors and Diversified. Its legal entity is Oriola Corporation. Its competitors include AmerisourceBergen, Wellgio Medical Oy, Tamro Finland, Verman and CabApp.
Company details
Oriola was established in 1997 and is headquartered in Espoo, Finland. Operations focus on the distribution of pharmaceutical drugs and supplements within the healthcare sector. Logistics and supply chain services are managed to support pharmacies, hospitals, and retailers across the region. The company operates primarily in the Nordic pharmaceutical market, ensuring compliance with regulatory standards for product handling and delivery.
- Headquarters Espoo, Finland
- Employees 816
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website oriola.com
- Social LinkedIn
- Legal Name Oriola Corp Class B
- Annual Revenue$2.24 B (USD)13.48as on Dec 31, 2025
- Net Profit-$31.96 M (USD)-35.32as on Dec 31, 2025
- EBITDA$22.68 M (USD)-17.17as on Dec 31, 2025
- Employee Count816
- Investments & AcquisitionsICT Health Support
& 1 more
Products & Services of Oriola
Oriola offers a comprehensive portfolio of products and services, including Pharmaceutical Distribution, Clinical Trial Services, and Dose Dispensing.
Distribution of medicines and health products to pharmacies and companies
Assistance with clinical trials and regulatory affairs processes
Automated dispensing of medications for accurate patient use
People of Oriola
11 people are tracked at Oriola (3 in leadership, 7 in board & advisors, 1 in team); the tracked headcount is 816.
| Name | Role | Group |
|---|---|---|
Hannes Hasselrot | Chief Commercial Officer | Leadership |
Katarina Gabrielson | CEO | Leadership |
Sari Pohjonen | CFO | Leadership |
Yrjö Närhinen | Director | Board & advisors |
Heikki Westerlund | Director | Board & advisors |
Ellinor Persdotter Nilsson | Director | Board & advisors |
Eva Nilsson Bågenholm | Vice Chairman | Board & advisors |
Harri Pärssinen | Director | Board & advisors |
Juko Hakala | Director | Board & advisors |
Nina Mähönen | Independent Board Member | Board & advisors |
Petter Sandström | General Counsel | Team |
Complete people profiles for Oriola
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Oriola
Oriola is a publicly listed company on the OMXHEX with ticker symbol ORIOLA in Finland, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date07 Mar 2006
- Listed onATHEX: OKDBV
- Listed entityOriola Corp Class B
- Exchange sectorDistribution services
- ISINFI0009014351
- Share price0.75 EUR (+0.67% on the day) · 2026-10-14
- Market capitalisation137,266,643.00 EUR
- EPS (diluted, trailing year)-0.11 EUR
- Dividend yield4.02%
- Volume (last session)5,012
Financials of Oriola
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.91B EUR | -27.2M EUR | 19.3M EUR |
| 2024 | 1.68B EUR | -20.1M EUR | 23.3M EUR |
| 2023 | 1.49B EUR | -20.7M EUR | 27.3M EUR |
| 2022 | 1.54B EUR | 27.0M EUR | 29.4M EUR |
| 2021 | 1.45B EUR | 11.3M EUR | 24.8M EUR |
Detailed financial statements for Oriola
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Oriola
Oriola has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ICT Health Support and Medinfo APS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
24/7 medical information and patient support services are provided. | medinfoaps.dk | Denmark | 2014 | Jan 2025 | •••• | |
Call center services are provided by ICT in Sweden. | icthealthsupport.se | Ljusdal, Sweden | 1978 | Jul 2017 | •••• |
Complete acquisition details for Oriola
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Oriola
4 dated milestones of Oriola across 28 years, from founding to its latest funding, stage changes and deals.
- Founded Oriola is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires ICT Health Support.
- Acquisition Acquires Medinfo APS.
Competitors of Oriola
Oriola has 5 listed competitors in our database. They include AmerisourceBergen, Wellgio Medical Oy, Tamro Finland, Verman and CabApp, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| wellgio.com | 2018 | Helsinki, Finland | – | 26 | Distributes pharmaceutical drugs to healthcare providers and clients efficiently. | |
| tamro.fi | 1895 | Vantaa, Finland | – | 187 | Provides distribution, logistics, and support for pharmaceuticals and health products. | |
| verman.fi | 1987 | Kerava, Finland | – | – | Residential apartments and flats are developed in various configurations. | |
| cabapp.fi | 2019 | Vantaa, Finland | – | – | Distributor of pharmaceutical products |
Detailed competitors of Oriola
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Oriola
The website of Oriola (oriola.com) receives about 10.4K visits a month.
- Monthly visits10.4K
▼ 35.9% vs previous month
Websites whose visitors overlap most with Oriola. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oriola-kd.com | 100% | 1.2K | – | View details | |
nordnet.fi | nordnet.fi | 56% | – | #15,124 | – |
| kauppalehti.fi | 37% | 7.9M | #9,536 | View details |
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Oriola (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Oriola
Complete news archive for Oriola
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oriola
Oriola was founded in 1997.
Oriola is headquartered in Espoo, Finland.
Oriola has 816 employees.
Annual revenue of Oriola is $2.24B as on Dec 31, 2025.
Oriola was established in 1997 and is headquartered in Espoo, Finland. Operations focus on the distribution of pharmaceutical drugs and supplements within the healthcare sector. Logistics and supply chain services are managed to support pharmacies, hospitals, and retailers across the region. The company operates primarily in the Nordic pharmaceutical market, ensuring compliance with regulatory standards for product handling and delivery.
Oriola's top competitors include AmerisourceBergen, Verman and CabApp.
Oriola offers Pharmaceutical Distribution, Clinical Trial Services, and Dose Dispensing.
Yes, Oriola is publicly traded on OMXHEX under the ticker symbol ORIOLA.
Oriola has made 2 acquisitions, including ICT Health Support, and Medinfo APS.
Oriola operates through Oriola Corporation.